Maria Stefania De Propris Selected Research

venetoclax

1/2023

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Stefania De Propris Research Topics

Disease

14	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 09/2002
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2023 - 01/2006
5	Disease Progression 04/2023 - 08/2003
4	Neoplasms (Cancer) 04/2023 - 04/2011
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2011 - 08/2009
3	Lymphoma (Lymphomas) 01/2023 - 03/2012
3	Residual Neoplasm 01/2023 - 01/2019
3	Philadelphia Chromosome 01/2023 - 04/2011
2	Leukemia 01/2024 - 04/2011
2	Acute Promyelocytic Leukemia 11/2014 - 12/2008
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2012 - 10/2011
2	Blast Crisis (Blast Phase) 06/2011 - 08/2009
2	Infections 08/2003 - 09/2002
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2023
1	Cytokine Release Syndrome 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Pneumonia (Pneumonitis) 01/2022
1	acquired Thrombotic thrombocytopenic purpura 01/2022
1	Splenomegaly 03/2014
1	Hemorrhage 03/2014
1	Hypersplenism (Anemia, Splenic) 03/2014
1	Thrombosis (Thrombus) 03/2014
1	Thrombocytopenia (Thrombopenia) 03/2014
1	Opportunistic Infections (Opportunistic Infection) 03/2014
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2014
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2012
1	Hematologic Diseases (Blood Diseases) 06/2011
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2011
1	Spontaneous Remission 07/2009
1	Pathologic Complete Response 02/2007
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2006
1	Bronchiolitis Obliterans Syndrome 03/2003
1	Hematologic Neoplasms (Hematological Malignancy) 01/2003
1	Neutropenia 09/2002

Drug/Important Bio-Agent (IBA)

7	Rituximab (Mabthera)FDA Link 01/2023 - 01/2014
5	ibrutinibIBA 12/2022 - 10/2020
4	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 04/2011
2	Chimeric Antigen ReceptorsIBA 04/2023 - 01/2023
2	Phosphotransferases (Kinase)IBA 01/2021 - 04/2011
2	AntigensIBA 01/2021 - 10/2011
2	fludarabineIBA 11/2020 - 09/2002
2	Monoclonal AntibodiesIBA 01/2014 - 06/2011
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2012 - 09/2002
2	Dasatinib (BMS 354825)FDA Link 12/2011 - 08/2009
1	Lysine (L-Lysine)FDA Link 01/2024
1	Histones (Histone)IBA 01/2024
1	MethyltransferasesIBA 01/2024
1	tisagenlecleucelIBA 04/2023
1	pembrolizumabIBA 01/2023
1	ribonucleotide polymeraseIBA 01/2023
1	pegaspargase (Oncaspar)FDA Link 01/2023
1	venetoclaxIBA 01/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021
1	ofatumumab FDA Link 11/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020
1	Drug CombinationsIBA 01/2019
1	MTOR InhibitorsIBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	CD34 Antigens (CD34 Antigen)IBA 11/2014
1	Chlorambucil (Leukeran)FDA Link 05/2014
1	AnticoagulantsIBA 03/2014
1	Oxidoreductases (Dehydrogenase)IBA 03/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	NucleophosminIBA 10/2011
1	Sialic Acid Binding Ig-like Lectin 3IBA 10/2011
1	AntibodiesIBA 10/2011
1	Therapeutic UsesIBA 10/2011
1	CD19 AntigensIBA 06/2011
1	Immunoglobulin Variable RegionIBA 04/2011
1	Tyrosine (L-Tyrosine)FDA Link 04/2011
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	Tyrosine Kinase InhibitorsIBA 12/2009
1	bcr-abl Fusion ProteinsIBA 12/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2009
1	Interleukin-4 (Interleukin 4)IBA 07/2009
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2008
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 12/2008
1	Immunoglobulin M (IgM)IBA 08/2008
1	OligonucleotidesIBA 01/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2003
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2003
1	Fluconazole (Zonal)FDA LinkGeneric 09/2002
1	Trimethoprim (Proloprim)FDA LinkGeneric 09/2002
1	Acyclovir (Aciclovir)FDA LinkGeneric 09/2002
1	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2002
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2002
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2002

Therapy/Procedure

5	Therapeutics 04/2023 - 02/2007
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2020
1	Cell Transplantation 01/2023
1	Splenectomy 03/2014
1	Transplantation 01/2012
1	Salvage Therapy 01/2012
1	Immunotherapy 06/2011
1	Ligation 08/2008
1	Stem Cell Transplantation 03/2003
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 03/2003
1	Autologous Transplantation 01/2003
1	Hematopoietic Stem Cell Mobilization 09/2002